1524 related articles for article (PubMed ID: 17199089)
1. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
2. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
[TBL] [Abstract][Full Text] [Related]
5. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
6. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
Boode B; Welzen V; Franke C; van Oostenbrugge R
Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
[TBL] [Abstract][Full Text] [Related]
7. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
Vaishnav AG; Pettigrew LC; Ryan S
Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
[TBL] [Abstract][Full Text] [Related]
8. Time trends in systemic thrombolysis in a large hospital-based stroke registry.
Singer OC; Hamann GF; Misselwitz B; Steinmetz H; Foerch C;
Cerebrovasc Dis; 2012; 33(4):316-21. PubMed ID: 22343969
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
[TBL] [Abstract][Full Text] [Related]
10. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
12. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
13. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
Simon JE; Sandler DL; Pexman JH; Hill MD; Buchan AM;
Age Ageing; 2004 Mar; 33(2):143-9. PubMed ID: 14960429
[TBL] [Abstract][Full Text] [Related]
14. Does intravenous rtPA benefit patients in the absence of CT angiographically visible intracranial occlusion?
Sylaja PN; Dzialowski I; Puetz V; Eliasziw M; Hill MD; Krol A; O'Reilly C; Demchuk AM
Neurol India; 2009; 57(6):739-43. PubMed ID: 20139502
[TBL] [Abstract][Full Text] [Related]
15. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
17. Thrombolytic therapy for acute stroke in the elderly: an emergent condition in developing countries.
Martins SC; Friedrich MA; Brondani R; de Almeida AG; de Araújo MD; Chaves ML; Berger JR; Massaro AR
J Stroke Cerebrovasc Dis; 2011; 20(5):459-64. PubMed ID: 20813552
[TBL] [Abstract][Full Text] [Related]
18. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
20. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
